Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Carcinoma, Basal Cell 2Basal Cell Nevus Syndrome 2Neoplasms 1Keratosis, Actinic 1

Interventions

tazarotene 2gusacitinib 2Photochemotherapy 2IPI-926 2HhAntag691 2Drug Evaluation 2Aminolevulinic Acid 21-phenyl-3,3-dimethyltriazene 2sonidegib 1merphos 1Vincristine 1Solutions 1Sirolimus 1Red Light 1Microarray Analysis 1Methotrexate 1Mental Status and Dementia Tests 1Mass Spectrometry 1Gene Expression Profiling 1Fluorouracil 1Etoposide 1Cyclophosphamide 1Comparative Genomic Hybridization 1Carnitine 1Carboplatin 1Blue Light 1Biopsy 1BMS-833923 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Basal Cell Nevus Syndrome × tazarotene × Clear all
NCT00489086 2020-10-29

Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face

UCSF Benioff Children's Hospital Oakland

Phase 2 Completed
36 enrolled 7 charts
Dermatologic

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell, Neoplasms

NCT00783965 2016-02-11

Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back

UCSF Benioff Children's Hospital Oakland

Phase 2 Completed
34 enrolled 9 charts
Dermatologic

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡